Hungary CBD Regulatory Market Report 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “CBD Regulatory report: Hungary” report has been added to ResearchAndMarkets.com’s offering.
CBD is not a controlled substance in Hungary, while the regulations depend on the intended use. Given the country’s tough stance on cannabis, it seems unlikely that it will move to decriminalise recreational use any time soon.
There is also no indication that a medicinal cannabis programme will be introduced, even though many other countries in Europe have already made this step.
This report offers a thorough overview of Hungary’s regulations relating to all aspects of CBD and related products, providing analysis on extracts and finished products, import and export, and both medical and recreational cannabis.
Key Topics Covered:
- Executive summary
- Outlook
- Hemp plant
- Extracts as a consumer product
- Finished product
- Import/export
- Medical cannabis
- Recreational cannabis
- Relevant laws
- Relevant bodies
For more information about this report visit https://www.researchandmarkets.com/r/cnc0mj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
